ACR Alpine Capital Research
ACR Alpine Capital Research reported 40 stocks worth $7.4B in its 13F filing for Q3 2026, filed Nov 2, 2026. Its largest holdings are GBIL (18.6%), MSFT (7.9%) and CVX (7.7%). Compared with Q2 2026, the fund opened new positions in BRC, TSN and ACN, added to GBIL, MSFT and LEN, trimmed JNJ, ARW and JPM and sold out of FDXF.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  GBIL Goldman Sachs ETF TR | $1.4B | 18.6% | 13.7M | +148K (+1%) | 8 of 8 | |
| 2 |  MSFT Microsoft Corp | $584M | 7.9% | 1.1M | +2,371 (+0%) | 8 of 8 | |
| 3 |  CVX Chevron Corp New | $568M | 7.7% | 2.8M | No change | 8 of 8 | |
| 4 |  JNJ Johnson & Johnson | $564M | 7.7% | 2.1M | −15K (−1%) | 8 of 8 | |
| 5 |  LEN Lennar Corp | $439M | 6.0% | 5.4M | +636K (+13%) | 8 of 8 | |
| 6 |  THO Thor Inds Inc | $400M | 5.4% | 5.8M | +254K (+5%) | 8 of 8 | |
| 7 |  VOD Vodafone Group PLC New F | $389M | 5.3% | 24.1M | +41K (+0%) | 8 of 8 | |
| 8 |  GM General Mtrs Co | $358M | 4.9% | 4.6M | +198K (+4%) | 8 of 8 | |
| 9 |  ELV Elevance Health Inc | $357M | 4.9% | 919K | +181K (+25%) | 2 of 8 | |
| 10 |  ARW Arrow Electrs Inc | $329M | 4.5% | 1.4M | −8,444 (−1%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 FDXF Fedex Fght Hldg Co Inc Common Stock | $231K | 1,533 |
NEW FORTRESS ENERGY INC | $44K | 120K |
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 2, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →ACR Alpine Capital Research 13F FAQ
What does ACR Alpine Capital Research own?
ACR Alpine Capital Research reported 40 stocks worth $7.4B in its 13F filing for Q3 2026, filed Nov 2, 2026. Its largest holdings are GBIL (18.6%), MSFT (7.9%) and CVX (7.7%). The table above lists every position in the filing (the top 10 without an account).
What did ACR Alpine Capital Research buy and sell in Q3 2026?
Compared with Q2 2026: 4 new positions, 24 added to, 9 trimmed and 2 sold out. New positions include BRC, TSN and ACN. It sold all of FDXF.
When will ACR Alpine Capital Research file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is ACR Alpine Capital Research's portfolio worth?
The Q3 2026 filing reports $7.4B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.